Table 2.
Variable | Group | n | M | SD | Mdn | IQR | Min | Max | p |
---|---|---|---|---|---|---|---|---|---|
testosterone (T1) | Study | 99 | 0.53 | 0.19 | 0.52 | 0.30 | 0.17 | 0.97 | 0.001 |
Control | 69 | 0.31 | 0.10 | 0.32 | 0.13 | 0.13 | 0.54 | ||
testosterone (T2) | Study | 99 | 0.41 | 0.14 | 0.38 | 0.14 | 0.14 | 0.85 | 0.001 |
androstendione (T1) | Study | 99 | 3.87 | 1.14 | 3.90 | 1.60 | 1.80 | 6.50 | 0.001 |
Control | 69 | 2.36 | 0.58 | 2.47 | 0.73 | 1.19 | 3.83 | ||
androstendione (T2) | Study | 99 | 3.03 | 0.71 | 3.10 | 1.00 | 1.50 | 4.50 | 0.026 |
SHBG (T1) | Study | 99 | 45.99 | 20.97 | 44.80 | 21.92 | 13.55 | 129.90 | 0.001 |
Control | 69 | 104.79 | 94.83 | 66.90 | 48.70 | 5.00 | 414.00 | ||
SHBG (T2) | Study | 99 | 148.08 | 38.94 | 145.10 | 55.70 | 78.10 | 223.10 | 0.001 |
FAI (T1) | Study | 99 | 1.40 | 0.86 | 1.20 | 0.99 | 0.38 | 5.55 | 0.001 |
Control | 69 | 0.60 | 1.22 | 0.40 | 0.36 | 0.05 | 10.22 | ||
FAI (T2) | Study | 99 | 0.30 | 0.14 | 0.27 | 0.17 | 0.11 | 0.88 | 0.001 |
LH (T1) | Study Control |
99 69 |
8.26 9.31 |
3.88 5.22 |
8.50 10.2 |
4.26 5.11 |
1.07 1.02 |
15.10 14.3 |
0.621 |
FSH (T1) | Study | 99 | 5.63 | 1.81 | 5.47 | 2.51 | 1.64 | 9.95 | 0.820 |
Control | 69 | 5.61 | 1.84 | 5.82 | 2.53 | 0.30 | 9.69 | ||
PRL (T1) | Study | 99 | 20.66 | 7.99 | 19.60 | 13.03 | 6.75 | 37.91 | 0.001 |
Control | 69 | 17.91 | 8.33 | 16.30 | 8.60 | 6.16 | 44.00 | ||
DHEA-S (T1) | Study | 99 | 258.51 | 81.79 | 254.10 | 119.15 | 45.60 | 413.00 | 0.348 |
Control | 69 | 239.70 | 98.19 | 211.00 | 151.00 | 58.40 | 487.00 | ||
ACTH (T1) | Study | 99 | 16.57 | 11.95 | 15.20 | 13.35 | 4.27 | 89.20 | 0.001 |
Control | 69 | 21.21 | 11.52 | 18.70 | 12.90 | 1.66 | 67.90 | ||
cortisol (T1) | Study | 99 | 22.25 | 9.61 | 21.00 | 11.90 | 8.02 | 49.10 | 0.001 |
Control | 69 | 15.79 | 7.51 | 14.30 | 9.30 | 5.63 | 39.50 |
T1—pre-treatment; T2—post-treatment; N—sample size; M—mean; SD—standard deviation; Mdn—median; IQR—interquartile range; Min—minimum; Max—maximum; p—p-value.